Vyas R - Search Results

1

Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, et al. Warrell RP Jr, et al. Among authors: vyas r. N Engl J Med. 1991 May 16;324(20):1385-93. doi: 10.1056/NEJM199105163242002. N Engl J Med. 1991. PMID: 1850498 Free article.

2

Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.

Wiernik PH, Dutcher JP, Paietta E, Hittelman WN, Vyas R, Strack M, Castaigne S, Degos L, Gallagher RE. Wiernik PH, et al. Among authors: vyas r. Leukemia. 1991 Jun;5(6):504-9. Leukemia. 1991. PMID: 2056773

3

Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis.

Vyas RC, Frankel SR, Agbor P, Miller WH Jr, Warrell RP Jr, Hittelman WN. Vyas RC, et al. Blood. 1996 Jan 1;87(1):218-26. Blood. 1996. PMID: 8547645 Free article. Clinical Trial.

4

PCR amplification of chromosome-specific DNA isolated from flow cytometry-sorted chromosomes.

Chang KS, Vyas RC, Deaven LL, Trujillo JM, Stass SA, Hittelman WN. Chang KS, et al. Among authors: vyas rc. Genomics. 1992 Feb;12(2):307-12. doi: 10.1016/0888-7543(92)90378-6. Genomics. 1992. PMID: 1740340

5

Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells.

Kuo MT, Vyas RC, Jiang LX, Hittelman WN. Kuo MT, et al. Among authors: vyas rc. Mol Cell Biol. 1994 Aug;14(8):5202-11. doi: 10.1128/mcb.14.8.5202-5211.1994. Mol Cell Biol. 1994. PMID: 7913517 Free PMC article.

6

A restriction fragment length polymorphism for human topoisomerase II: possible relationship to drug-resistance.

Zwelling LA, Mayes J, Deisseroth K, Hinds M, Grant G, Pathak S, Ledley FD, Vyas R, Hittelman W. Zwelling LA, et al. Among authors: vyas r. Cancer Commun. 1990;2(11):357-61. doi: 10.3727/095535490820874047. Cancer Commun. 1990. PMID: 1978687

7

Genotoxic effects of MeCCNU on human peripheral blood lymphocytes.

Vyas RC, Adhvaryu SG, Shah VC. Vyas RC, et al. Toxicol Lett. 1988 Nov;44(1-2):153-9. doi: 10.1016/0378-4274(88)90141-5. Toxicol Lett. 1988. PMID: 3188073

8

Overcoming reprogramming resistance of Fanconi anemia cells.

Müller LU, Milsom MD, Harris CE, Vyas R, Brumme KM, Parmar K, Moreau LA, Schambach A, Park IH, London WB, Strait K, Schlaeger T, Devine AL, Grassman E, D'Andrea A, Daley GQ, Williams DA. Müller LU, et al. Among authors: vyas r. Blood. 2012 Jun 7;119(23):5449-57. doi: 10.1182/blood-2012-02-408674. Epub 2012 Feb 27. Blood. 2012. PMID: 22371882 Free PMC article.

9

Complex translocation involving chromosomes #1, #9, and #22 in a patient with chronic myelogenous leukemia.

Adhvaryu SG, Vyas RC, Jani KH, Balar DB. Adhvaryu SG, et al. Among authors: vyas rc. Cancer Genet Cytogenet. 1988 Jun;32(2):277-80. doi: 10.1016/0165-4608(88)90291-9. Cancer Genet Cytogenet. 1988. PMID: 3163266

10

Effects of CCNU therapy on human chromosomes.

Vyas RC, Adhvaryu SG, Shah VC. Vyas RC, et al. Mutat Res. 1988 Oct;206(2):163-6. doi: 10.1016/0165-1218(88)90155-3. Mutat Res. 1988. PMID: 3173387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page